News
Link to press release.
Read MoreThe round will accelerate US2.AI’s global commercial and regulatory rollout SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced it has raised US$15 million in a series A round led by IHH Healthcare and…
Read MoreAI Med feature of AI Champions
Read MoreA profile of Dr Carolyn Lam in Tattler Asia.
Read MoreAutomated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study
Read More